Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-α therapy

被引:57
|
作者
Mallbris, L
Ljungberg, A
Hedblad, MA
Larsson, P
Ståhle-Bäckdahl, M
机构
[1] Karolinska Inst, Dept Med, Unit Dermatol, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden
关键词
D O I
10.1067/mjd.2003.228
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We describe a patient with widespread and progressive cutaneous sarcoidosis who was successfully treated with anti-tumor necrosis factor-alpha monoclonal antibody, infliximab, suggesting that inhibition of tumor necrosis factor-alpha may be useful as targeted treatment in cutaneous sarcoidosis.
引用
收藏
页码:290 / 293
页数:4
相关论文
共 50 条
  • [1] Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
    Yee, AMF
    Pochapin, MB
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) : 27 - 31
  • [2] Sarcoidosis During Anti-Tumor Necrosis Factor-α Therapy: No Relapse After Rechallenge
    van der Stoep, Deborah
    Braunstahl, Gert-Jan
    van Zeben, Jende
    Wouters, Jacques
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) : 2847 - 2848
  • [3] Interstitial pneumonitis and anti-tumor necrosis factor-α therapy
    Roos, Jonathan C. P.
    Chilvers, Edwin R.
    Ostor, Andrew J. K.
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (01) : 238 - 239
  • [4] Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-α therapy
    Salvatierra, Juan
    Magro-Checa, Cesar
    Rosales-Alexander, Jose L.
    Raya-Alvarez, Enrique
    [J]. RHEUMATOLOGY, 2011, 50 (07) : 1346 - 1348
  • [5] Anti-tumor necrosis factor-α in asthma
    Erin, Edward M.
    Kon, Onn Min
    Barnes, Peter J.
    Hansel, Trevor T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (03) : 288 - 289
  • [6] Histoplasmosis after treatment with anti-tumor necrosis factor-α therapy
    Wood, KL
    Hage, CA
    Knox, KS
    Kleiman, MB
    Sannuti, A
    Day, RB
    Wheat, LJ
    Twigg, HL
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (09) : 1279 - 1282
  • [7] Nontuberculous Mycobacteria Infections and Anti-Tumor Necrosis Factor-α Therapy
    Winthrop, Kevin L.
    Chang, Eric
    Yamashita, Shellie
    Lademarco, Michael F.
    LoBue, Philip A.
    [J]. EMERGING INFECTIOUS DISEASES, 2009, 15 (10) : 1556 - 1561
  • [8] Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease
    Sack, MN
    [J]. PHARMACOLOGY & THERAPEUTICS, 2002, 94 (1-2) : 123 - 135
  • [9] The CD4+ Lymphopenic Sarcoidosis Phenotype Is Highly Responsive to Anti-Tumor Necrosis Factor-α Therapy
    Crouser, Elliott D.
    Lozanski, Gerard
    Fox, Charity C.
    Hauswirth, David W.
    Raveendran, Rekha
    Julian, Mark W.
    [J]. CHEST, 2010, 137 (06) : 1432 - 1435
  • [10] Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-α therapy
    Yee, Arthur M. F.
    [J]. RESPIRATORY MEDICINE, 2023, 206